by Automated CPR devices are medical devices that provide chest compressions to a person who is unconscious and not breathing normally due to cardiac arrest. These devices deliver uninterrupted chest compressions at a consistent depth and rate to the patient, allowing the rescuer to focus on other life-saving procedures such as providing airway management and rescue breathing. Automated CPR devices are considered more effective than manual CPR as they minimize interruptions in chest compressions and help maintain optimal compression rates of 100-120 compressions per minute. The global Automated CPR Devices Market is estimated to be valued at US$ 127.06 Mn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The prevalence of cardiac arrests is on the rise globally due to increasing elderly population and growing burden of cardiovascular diseases. According to the American Heart Association, over 350,000 out-of-hospital cardiac arrests occur annually in the United States. Timely intervention through effective CPR can enhance cardiac arrest survival rates. Automated CPR devices help standardize the CPR procedure and ensure optimal chest compressions. This is driving the demand for automated CPR devices from hospitals, emergency medical facilities, and pre-hospital settings.
SWOT Analysis
Strength: Automated CPR devices provide uninterrupted chest compressions at the optimal rate and depth compared to manual CPR, which can help improve patient outcomes.
Weakness: The high costs associated with automated CPR devices can limit their adoption especially in low and middle-income countries. Proper training is also required for the use of automated devices.
Opportunity: Growing public access defibrillation programs and guidelines recommending longer resuscitation attempts are expanding the market potential for automated CPR devices. Various technological advancements are further enhancing the capabilities of these devices.
Threats: Availability of low-cost generic manual CPR alternatives poses competition. Reimbursement policies also impact the sales and procurement of automated CPR devices.
Key Takeaways
The global automated CPR devices market demand is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to reach US$ 127.06 Mn in 2024, growing at an estimated CAGR of 10%.
Regional analysis: North America currently dominates the automated CPR devices market owing to favorable public access defibrillation programs and reimbursement scenario. However, Asia Pacific is projected to experience the fastest growth during the forecast period supported by rising healthcare investments, increasing cardiac arrest incidence, and growing awareness about emergency cardiac care.
Key players: Key players operating in the automated CPR devices market are AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd. These players are focusing on technological innovations to make the devices more portable, affordable and easy-to-use.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
